Silybinin is regarded as the most potent flavonoid against liver disease and can prevent NASH through activation of CFLAR expression and inhibition of JNK phosphorylation, which can modulate NASH-associated liver lipid metabolism, insulin resistance, and oxidative stress (Liu et al., 2019). Here, MAPK8 is linked to metabolic dysfunction-associated steatohepatitis.